VERICEL CORPORATION Net Cash Provided by (Used in) Investing Activities, Continuing Operations
VERICEL CORPORATION (VCEL) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of -$70.00 thousand for the 3-month period ending 2017-03-31, per its 10-Q filed 2017-05-10.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2017-05-10
- VERICEL CORPORATION net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-03-31 was -$70.00K, a 187.50% decline year-over-year.
- VERICEL CORPORATION net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-12-31 was -$101.00K.
- VERICEL CORPORATION net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-09-30 was -$333.00K.
- VERICEL CORPORATION net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-06-30 was -$1.06M.
- VERICEL CORPORATION net cash provided by (used in) investing activities, continuing operations for fiscal 2016 was -$1.42M.
- VERICEL CORPORATION net cash provided by (used in) investing activities, continuing operations for fiscal 2015 was -$2.39M.
- VERICEL CORPORATION net cash provided by (used in) investing activities, continuing operations for fiscal 2014 was -$2.18M.
- VERICEL CORPORATION net cash provided by (used in) investing activities, continuing operations for fiscal 2013 was -$40.00K.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 270 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 273 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 276 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 279 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 282 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 285 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 288 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 291 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 294 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 297 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 300 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2017-03-31 | -$70.00K 10-Q · filed 2017-05-10 | -$171.00K derived: sum of 2 quarters · filed 2017-05-10 | -$504.00K derived: sum of 3 quarters · filed 2017-05-10 | -$1.56M derived: sum of 4 quarters · filed 2017-05-10 | |||||||||||
| 2016-12-31 | -$101.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-13 | -$434.00K derived: sum of 2 quarters · filed 2017-03-13 | -$1.50M derived: sum of 3 quarters · filed 2017-03-13 | -$1.42M 10-K · filed 2017-03-13 | |||||||||||
| 2016-09-30 | -$333.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | -$1.39M derived: sum of 2 quarters · filed 2016-11-07 | -$1.31M 10-Q · filed 2016-11-07 | -$1.41M derived: sum of 4 quarters · filed 2017-05-10 | |||||||||||
| 2016-06-30 | -$1.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | -$981.00K 10-Q · filed 2016-08-08 | -$1.08M derived: sum of 3 quarters · filed 2017-05-10 | -$1.85M derived: sum of 4 quarters · filed 2017-05-10 | |||||||||||
| 2016-03-31 | $80.00K 10-Q · filed 2017-05-10 | -$17.00K derived: sum of 2 quarters · filed 2017-05-10 | -$792.00K derived: sum of 3 quarters · filed 2017-05-10 | -$1.99M derived: sum of 4 quarters · filed 2017-05-10 | |||||||||||
| 2015-12-31 | -$97.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-13 | -$872.00K derived: sum of 2 quarters · filed 2017-03-13 | -$2.07M derived: sum of 3 quarters · filed 2017-03-13 | -$2.39M 10-K · filed 2017-03-13 | |||||||||||
| 2015-09-30 | -$775.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | -$1.98M derived: sum of 2 quarters · filed 2016-11-07 | -$2.29M 10-Q · filed 2016-11-07 | -$2.94M derived: sum of 4 quarters · filed 2017-03-13 | |||||||||||
| 2015-06-30 | -$1.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | -$1.52M 10-Q · filed 2016-08-08 | -$2.17M derived: sum of 3 quarters · filed 2017-03-13 | -$4.73M derived: sum of 4 quarters · filed 2017-03-13 | |||||||||||
| 2015-03-31 | -$318.00K 10-Q · filed 2016-05-10 | -$964.00K derived: sum of 2 quarters · filed 2017-03-13 | -$3.53M derived: sum of 3 quarters · filed 2017-03-13 | -$2.50M derived: sum of 4 quarters · filed 2017-03-13 | |||||||||||
| 2014-12-31 | -$646.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-13 | -$3.21M derived: sum of 2 quarters · filed 2017-03-13 | -$2.18M derived: sum of 3 quarters · filed 2017-03-13 | -$2.18M 10-K · filed 2017-03-13 | |||||||||||
| 2014-09-30 | -$2.57M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-13 | -$1.53M derived: sum of 2 quarters · filed 2015-11-13 | -$1.53M 10-Q · filed 2015-11-13 | -$1.53M derived: sum of 4 quarters · filed 2016-03-14 | |||||||||||
| 2014-06-30 | $1.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-12 | $1.04M 10-Q · filed 2015-08-12 | $1.04M derived: sum of 3 quarters · filed 2016-03-14 | $1.04M derived: sum of 4 quarters · filed 2016-03-14 | |||||||||||
| 2014-03-31 | $0.00 10-Q · filed 2015-05-14 | $0.00 derived: sum of 2 quarters · filed 2016-03-14 | $0.00 derived: sum of 3 quarters · filed 2016-03-14 | -$22.00K derived: sum of 4 quarters · filed 2016-03-14 | -$5.50M 10-Q · filed 2014-05-15 | ||||||||||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-14 | $0.00 derived: sum of 2 quarters · filed 2016-03-14 | -$22.00K derived: sum of 3 quarters · filed 2016-03-14 | -$40.00K 10-K · filed 2016-03-14 | -$5.50M 10-K · filed 2014-03-13 | ||||||||||
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13 | -$22.00K derived: sum of 2 quarters · filed 2014-11-13 | -$40.00K 10-Q · filed 2014-11-13 | -$144.00K derived: sum of 4 quarters · filed 2015-03-25 | -$5.50M 10-Q · filed 2013-11-12 | ||||||||||
| 2013-06-30 | -$22.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | -$40.00K 10-Q · filed 2014-08-14 | -$144.00K derived: sum of 3 quarters · filed 2015-03-25 | -$227.00K derived: sum of 4 quarters · filed 2015-03-25 | -$5.50M 10-Q · filed 2013-08-07 | ||||||||||
| 2013-03-31 | -$18.00K 10-Q · filed 2014-05-15 | -$122.00K derived: sum of 2 quarters · filed 2015-03-25 | -$205.00K derived: sum of 3 quarters · filed 2015-03-25 | -$209.00K derived: sum of 4 quarters · filed 2015-03-25 | -$5.48M 10-Q · filed 2013-05-08 | ||||||||||
| 2012-12-31 | -$104.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-25 | -$187.00K derived: sum of 2 quarters · filed 2015-03-25 | -$191.00K derived: sum of 3 quarters · filed 2015-03-25 | -$273.00K 10-K · filed 2015-03-25 | -$5.46M 10-K · filed 2013-03-18 | ||||||||||
| 2012-09-30 | -$83.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | -$87.00K derived: sum of 2 quarters · filed 2013-11-12 | -$169.00K 10-Q · filed 2013-11-12 | -$397.00K derived: sum of 4 quarters · filed 2014-03-13 | -$5.36M 10-Q · filed 2012-11-08 | ||||||||||
| 2012-06-30 | -$4.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-07 | -$86.00K 10-Q · filed 2013-08-07 | -$314.00K derived: sum of 3 quarters · filed 2014-03-13 | -$705.00K derived: sum of 4 quarters · filed 2014-03-13 | -$5.27M 10-Q · filed 2012-08-07 | ||||||||||
| 2012-03-31 | -$82.00K 10-Q · filed 2013-05-08 | -$310.00K derived: sum of 2 quarters · filed 2014-03-13 | -$701.00K derived: sum of 3 quarters · filed 2014-03-13 | -$965.00K derived: sum of 4 quarters · filed 2014-03-13 | -$5.27M 10-Q · filed 2012-05-10 | ||||||||||
| 2011-12-31 | -$228.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-13 | -$619.00K derived: sum of 2 quarters · filed 2014-03-13 | -$883.00K derived: sum of 3 quarters · filed 2014-03-13 | -$1.03M 10-K · filed 2014-03-13 | -$5.19M 10-K · filed 2012-03-15 | ||||||||||
| 2011-09-30 | -$391.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08 | -$655.00K derived: sum of 2 quarters · filed 2012-11-08 | -$803.00K 10-Q · filed 2012-11-08 | -$4.96M 10-Q · filed 2011-11-08 | |||||||||||
| 2011-06-30 | -$264.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-07 | -$412.00K 10-Q · filed 2012-08-07 | |||||||||||||
| 2011-03-31 | -$148.00K 10-Q · filed 2012-05-10 | ||||||||||||||
| 2010-12-31 | $4.70M 10-K · filed 2013-03-18 | ||||||||||||||
| 2010-09-30 | -$132.00K 10-Q · filed 2011-11-08 | ||||||||||||||
| 2010-06-30 | -$5.12M 10-K · filed 2013-03-18 | ||||||||||||||
| 2009-06-30 | $5.96M 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 | |
| Taysha Gene Therapies, Inc. (TSHA) | United States | $1.564B | -14.80 |